companydata.dkNOVOZYMES BIOINDUSTRIAL CHINA A/S: Financial statements 2024
CVR: 21599042
NOVOZYMES BIOINDUSTRIAL CHINA A/S (CVR 21599042) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1 and a net result of DKK 394,633,084 compared with DKK 261,035,112 the year before. Equity amounted to DKK 1,299,155,966. The solvency ratio was 99.7%.
- Gross Profit
- -1 kr.
- Profit/Loss
- 394,633,084 kr.
- Equity
- 1,299,155,966 kr.
- Total Assets
- 1,302,551,053 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -1 | 394.6 mio. | 1.3 mia. | - |
| 2023 | - | 1 | 261 mio. | 1 mia. | - |
| 2022 | - | -1 | 132.7 mio. | 903.5 mio. | 0 |
| 2021 | - | -33 t. | 56.1 mio. | 828.8 mio. | 0 |
| 2020 | - | -32 t. | 45.6 mio. | 817.8 mio. | 0 |
How creditworthy is NOVOZYMES BIOINDUSTRIAL CHINA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
As of September 18, 2024, Lisbet Kragelund has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of September 18, 2024, Randi Camilla Kinch Jensen has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of September 18, 2024, Lisbet Kragelund is registered as director of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of September 18, 2024, Randi Camilla Kinch Jensen has stepped down as adm. dir. of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2023. Gross profit came to DKK 1, and the net result was DKK 261,035,112.
As of June 7, 2024, EY Godkendt Revisionspartnerselskab has been appointed auditor of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of June 7, 2024, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
About NOVOZYMES BIOINDUSTRIAL CHINA A/S
NOVOZYMES BIOINDUSTRIAL CHINA A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1999. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Lisbet Kragelund. The company is owned by NOVOZYMES A/S. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 119,380,365 compared with DKK 394,633,084 the year before. Equity amounted to DKK 1,018,536,331.